Lexicon Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan, and we're continuing the 2020 healthcare conference today with Lexicon.
We're going to host a Q&A session with the management team immediately after this presentation. It's going to be just down the hall in the Yorkshire Room, so come to that after if you want to hear more. But for the presentation, I'm going to turn it over to the company's CEO, Lonnel Coats.
Thank you, Jessica. And as always, I will make this presentation on behalf of all the extraordinary men and women at Lexicon who work tirelessly to bring our innovations forward to patients.
Today, I'll be making forward-looking statements. In some of those statements, there will be risks. Our risks are identified in our SEC filings.
So let me jump right in. Lexicon's scientific platform has produced 2 approved products and a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |